Patient organization
The patient comes first
For Bayer, one of the world's leading specialty pharmaceutical companies, patients' health always comes first. Exchanging ideas and information with patient organizations on the basis of mutual trust is an important component of our work.
Such cooperation helps us to understand the needs of patients as they come to terms with their illness. This enables us to gear our research and development to these needs and to continue working on improved, new drugs and therapies.
Bayer cooperates with patient organizations in all kinds of therapeutic areas. We attach great importance to transparency in this context and protect the independence of our cooperation partners.
Our principles
Cooperation between Bayer and patient organizations is based on the following principles.
- In order to provide patients with quality medical healthcare, a partnership with a patient organization pursues a specific objective concentrating on one or more of the following areas:
- raising awareness for certain diseases by improving diagnostic possibilities and preventive measures, knowing the patients' prospects and needs,
- understanding diseases and making sure that patients receive the best medical treatment available,
- improving the information provided to the patients,
- supporting medical innovations.
- Bayer and the patient organizations comply with international and national laws and regulations.
- Cooperation with a patient organization should neither influence decisions on a therapy nor promote or support specific therapies.
- Bayer respects the neutrality and independence of patient organizations. Cooperation is based on a partnership between equals in which transparency and clarity are fundamental principles. This is why we also provide information on the extent and nature of support.
Overview of cooperation with patient organizations in Europe in 2019
The following is a list of patient organizations with which Bayer and its affiliated companies in Europe cooperated in 2019.
Headquarters:
| Bayer Company | Bayer AG |
| Contract date | 01.11.2019 |
| Amount | 90.000 EUR |
| Purpose of interaction | Sponsorship of annual patient representative meeting |
| Bayer Company | Bayer AG |
| Contract date | 01.06.2019 |
| Amount | 25.000 EUR |
| Purpose of interaction | Sponsorship of World Scleroderma Day |
| Bayer Company | Bayer AG |
| Contract date | 01.02.2019 |
| Amount | 5.000 EUR |
| Purpose of interaction | Membership fee for EURORDIS |
| Bayer Company | Bayer AG |
| Contract date | 05.07.2019 |
| Amount | 120.000 EUR |
| Purpose of interaction | Support of 2 Events (Working conference in Porto in Nov 2019 & development of a concept for a European Stroke Forum) |
| Bayer Company | Bayer AG |
| Contract date | 12.02.2019 |
| Amount | 2.380 EUR |
| Purpose of interaction | „Förderkreis-Mitgliedschaft 2019“ |
| Bayer Company | Bayer AG |
| Contract date | 04.02.2019 |
| Amount | 5.000 EUR |
| Purpose of interaction | Hotel in Toronto to attend the DR Barometer Global Advisory Committee meeting and to attend partner meetings to plan collaboration activities between the International Federation of Ageing and the IAPB |
| Bayer Company | BCC AG |
| Contract date | 28.05.2019 |
| Amount | 659,50 CHF |
| Purpose of interaction | Hotel in Toronto to attend the DR Barometer Global Advisory Committee meeting and to attend partner meetings to plan collaboration activities between the International Federation of Ageing and the IAPB |
| Bayer Company | BCC AG |
| Contract date | 28.05.2019 |
| Amount | 8.109,95 CHF |
| Purpose of interaction | Travel arrangements Toronto, DR Barometer SC Meeting |
| Bayer Company | BCC AG |
| Contract date | 09.04.2019 |
| Amount | 614,16 CHF |
| Purpose of interaction | Congress Registration Paris, EURETINA to attend congress activities |
| Bayer Company | BCC AG |
| Contract date | 09.04.2019 |
| Amount | 162,92 CHF |
| Purpose of interaction | Travel arrangements Paris, EURETINA to attend the DR Barometer Global Advisory Committee meeting and congress activities |
| Bayer Company | BCC AG |
| Contract date | 12.12.2019 |
| Amount | 20.000 USD |
| Purpose of interaction | Sponsorship of the World Sight Day (WSD) Photo Competition, an awareness raising campaign in the lead up to WSD which is an annual day of awareness to focus global attention on blindness and vision impairment. |
| Bayer Company | BCC AG |
| Contract date | 13.12.2019 |
| Amount | 50.000 GBP |
| Purpose of interaction | Sponsorship of the International Agency for Prevention of Blindness, in partnership with the Singapore Eye Research Institute, 2020 Global Assembly. The Event is the quadrennial premier global event focussed on all aspects of public health issues related to blindness and visual impairment. |
| Bayer Company | Bayer AG |
| Contract date | 13.12.2019 |
| Amount | 100.000 USD |
| Purpose of interaction | Annual sponsorship of the International Agency for Prevention of Blindness anto undertake work in advocating for the implementation of the Universal Eye Health and the Global Action Plan, support the development, roll out and uptake of the WHO’s ‘World Report on Vision’, continued engagement of the Sustainable Development Goals and provision of membership services. |
| Bayer Company | BCC AG |
| Contract date | 09.04.2019 |
| Amount | 171,55 CHF |
| Purpose of interaction | Travel arrangements Paris, EURETINA to attend the DR Barometer Global Advisory Committee meeting and congress activities |
| Bayer Company | BCC AG |
| Contract date | 28.05.2019 |
| Amount | 219,08 CHF |
| Purpose of interaction | Hotel in Toronto to attend the DR Barometer Global Advisory Committee meeting |
| Bayer Company | BCC AG |
| Contract date | 28.05.2019 |
| Amount | 8.389,75 CHF |
| Purpose of interaction | Travel arrangements Toronto to attend the DR Barometer Global Advisory Committee |
| Bayer Company | BCC AG |
| Contract date | 22.05.2019 |
| Amount | 68.500 Euro |
| Purpose of interaction | Anunal sponsorship to support the IDF's involvement in the DR Barometer program to: • Work with partners, other experts and policymakers to support stakeholder utilisation of the Report’s findings • Support healthcare professionals through the provision of education on DR • Ensure promotion of Program activities to relevant healthcare professionals through various channels including a DR Barometer Symposium at the IDF Annual Congress |
| Bayer Company | BCC AG |
| Contract date | 11.01.2019 |
| Amount | 68.000 EUR |
| Purpose of interaction | 2019 Sponsorship of Pedalea Hemophilia |
| Bayer Company | BCC AG |
| Contract date | 21.01.2019 |
| Amount | 37.000 EUR |
| Purpose of interaction | EHC conference Sponsorship |
| Bayer Company | BCC AG |
| Contract date | 21.01.2019 |
| Amount | 45.000 EUR |
| Purpose of interaction | ECH Annual Sponsorship |
Europe:
Reports can be received from
UAB Bayer Baltic Republics (Estonia, Latvia, Lithuania)
Alina Tikuišiene MD
Zirmunu str. 68A
LT-09124 Vilnius/Lithunia
Reports can be received from
UAB Bayer Baltic Republics (Estonia, Latvia, Lithuania)
Alina Tikuišiene MD
Zirmunu str. 68A
LT-09124 Vilnius/Lithunia
Reports can be received from
Bayer AB- Bayer Scandinavia
Iina Wargh
Gustav III:s Boulevard 56
169 26 Solna
Reports can be received from
SC Bayer SRL
Bayer Pharmaceuticals Division
Sos. Pipera nr. 42., Sector 2
NUSCO Tower fl. 1,16,17
020112, Bucharest
Romania
Reports can be received from
Bayer Pharma d.o.o.
Jelena Tokanovic
Omladinskih brigada 88b
Belgrade
Reports can be received from
Bayer d.o.o.
Lucija Zlodi Gosnik
Bravnicarjeva 13
1000 Ljubljana